David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Helios Technologies
HLIO
$2.44B
| $9.8M | ﹤0.01% |
109,843
+56,905
| +107% | +$4.37M |
|
1727
Allogene Therapeutics
ALLO
$743M
| $9.8M | ﹤0.01% |
4,710,735
+1,946,959
| +70% | +$4.28M |
|
1728
PUT
Axsome Therapeutics
AXSM
$10.7B
| $9.79M | ﹤0.01% |
+40,000
| New | +$8.67M |
|
1729
Angi Inc
ANGI
$202M
| $9.77M | ﹤0.01% |
1,641,443
-205,094
| -11% | -$1.27M |
|
1730
Armstrong World Industries
AWI
$7.62B
| $9.75M | ﹤0.01% |
+60,755
| New | +$9.93M |
|
1731
Flutter Entertainment
FLUT
$17.7B
| $9.74M | ﹤0.01% |
95,300
-28,095
| -23% | -$2.9M |
|
1732
Organon & Co
OGN
$3.61B
| $9.73M | ﹤0.01% |
718,753
-1,925,799
| -73% | -$23M |
|
1733
Dole
DOLE
$1.27B
| $9.71M | ﹤0.01% |
707,729
+195,945
| +38% | +$2.85M |
|
1734
Indivior Pharmaceuticals
INDV
$4.27B
| $9.68M | ﹤0.01% |
236,034
+32,049
| +16% | +$1.16M |
|
|
MDA
1735
MDA Space Ltd
MDA
$4.78B
| $9.68M | ﹤0.01% |
234,500
+78,483
| +50% | +$2.85M |
|
1736
CALL
Cencora
COR
$61.9B
| $9.68M | ﹤0.01% |
34,200
-4,700
| -12% | -$1.35M |
|
1737
Whirlpool
WHR
$2.65B
| $9.67M | ﹤0.01% |
+245,404
| New | +$11.5M |
|
1738
Varex Imaging
VREX
$781M
| $9.65M | ﹤0.01% |
925,254
-10,579
| -1% | -$114K |
|
1739
PUT
Cleveland-Cliffs
CLF
$6.5B
| $9.65M | ﹤0.01% |
1,027,200
-111,400
| -10% | -$1.23M |
|
1740
Columbia Sportswear
COLM
$3.04B
| $9.63M | ﹤0.01% |
155,801
-214,754
| -58% | -$13.3M |
|
1741
Exponent
EXPO
$3.32B
| $9.63M | ﹤0.01% |
163,892
-28,204
| -15% | -$1.73M |
|
1742
CALL
AT&T
T
$176B
| $9.62M | ﹤0.01% |
464,600
-322,100
| -41% | -$7.99M |
|
1743
Kinsale Capital Group
KNSL
$8.89B
| $9.6M | ﹤0.01% |
29,101
+21,193
| +268% | +$6.82M |
|
1744
Anterix
ATEX
$1.79B
| $9.57M | ﹤0.01% |
92,990
+87,294
| +1,533% | +$5.12M |
|
1745
RxSight
RXST
$258M
| $9.57M | ﹤0.01% |
1,985,215
+25,483
| +1% | +$154K |
|
1746
Frontier Group Holdings
ULCC
$1.36B
| $9.57M | ﹤0.01% |
1,209,528
+1,003,850
| +488% | +$5.18M |
|
1747
Rezolute
RZLT
$493M
| $9.56M | ﹤0.01% |
1,839,357
+73,377
| +4% | +$273K |
|
1748
uniQure
QURE
$3.49B
| $9.56M | ﹤0.01% |
207,629
+46,915
| +29% | +$1.23M |
|
1749
MDU Resources
MDU
$4.19B
| $9.56M | ﹤0.01% |
450,754
-19,834
| -4% | -$431K |
|
1750
Ouster
OUST
$2.66B
| $9.55M | ﹤0.01% |
152,728
-689,361
| -82% | -$23.2M |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.